Effect of mengovirus replication on choline metabolism and membrane formation in novikoff hepatoma cells.
Infection of Novikoff rat hepatoma cells (subline NlSL-67) with mengovirus resulted in a two- to threefold increase in the rate of choline incorporation into membrane phosphatidylcholine at about 3 hr after infection, without affecting the rate of transport of choline into the cell or its phosphorylation. The time course of virus-stimulated phosphatidylcholine synthesis was compared with the time courses of other virus-induced processes during a single cycle of replication. The formation of viral ribonucleic acid (RNA) polymerase and of viral RNA commenced about 1 hr earlier than the virus-stimulated choline incorporation. Further, isopycnic centrifugation of cytoplasmic extracts indicated that the excess of phosphatidylcholine synthesized by infected cells is not located in the membrane structures associated with the viral RNA replication complex, but with structures of a lower density (1.08 to 1.14 g/cc). These membrane structures probably represent the smooth vesicles which accumulate in the cytoplasm of infected cells during the period of increased phosphatidylcholine synthesis between 3 and 5 hr after infection. They are formed with both newly synthesized phosphatidylcholine and phosphatidylcholine present prior to infection. However, concomitant protein synthesis is not required for the stimulated synthesis of membranes; the effect was not inhibited by treating the cells with inhibitors of protein synthesis at 3 hr after infection, although virus production was inhibited about 90% and virus-induced cell degeneration was markedly reduced and delayed. Production of mature virus began normally at about the same time as the stimulation of phosphatidylcholine synthesis. Treatment of infected cells with puromycin at 2 hr, on the other hand, completely inhibited the stimulation of phosphatidylcholine synthesis.
D000818:Animals; D002247:Carbon Isotopes; D006528:Carcinoma, Hepatocellular / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D002462:Cell Membrane / Q000378:metabolism*; D002499:Centrifugation, Density Gradient; D002794:Choline / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D046508:Culture Techniques; D003593:Cytoplasm; D003609:Dactinomycin / Q000494:pharmacology; D004686:Encephalomyocarditis virus / Q000254:growth & development* / Q000378:metabolism / Q000472:pathogenicity; D006150:Guanine Nucleotides / Q000378:metabolism; D008055:Lipids / Q000032:analysis; D008113:Liver Neoplasms; D008854:Microscopy, Electron; D010713:Phosphatidylcholines / Q000096:biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012316:RNA Nucleotidyltransferases / Q000096:biosynthesis; D012367:RNA, Viral / Q000096:biosynthesis; D051381:Rats; D013395:Sucrose; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014779:Virus Replication
D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D008055:Lipids; D010713:Phosphatidylcholines; D012367:RNA, Viral; D014316:Tritium; D003609:Dactinomycin; D011691:Puromycin; D013395:Sucrose; D012316:RNA Nucleotidyltransferases; D002794:Choline; D014529:Uridine